4.7 Article

Polydopamine Nanoparticles for Combined Chemo- and Photothermal Cancer Therapy

Journal

NANOMATERIALS
Volume 7, Issue 7, Pages -

Publisher

MDPI
DOI: 10.3390/nano7070160

Keywords

polydopamine nanoparticles; photothermal; chemotherapy; cisplatin

Funding

  1. National Institute of Health [1DP2EB016572-01]

Ask authors/readers for more resources

Cancer therapy with two different modalities can enhance treatment efficacy and reduce side effects. This paper describes a new method for combined chemo- and photothermal therapy of cancer using poly dopamine nanoparticles (PDA-NPs), where PDA-NPs serve not only as a photothermal agent with strong near infrared absorbance and high energy conversion efficiency, but also as a carrier to deliver cisplatin via interaction between cisplatin and catechol groups on PDA-NPs. Polyethylene glycol (PEG) was introduced through Michael addition reaction to improve the stability of PDA-NPs in physiological condition. A remarkable synergistic therapeutic effect has been achieved compared with respective single treatments. This work suggests that the PDA-based nanoplatform can be a universal scaffold for combined chemo- and photothermal therapy of cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available